Development of a method to multiplex ChIP-SEQ and ChIP-chip experiments

Information

  • Research Project
  • 7802006
  • ApplicationId
    7802006
  • Core Project Number
    R43HG005282
  • Full Project Number
    1R43HG005282-01
  • Serial Number
    5282
  • FOA Number
    PA-09-080
  • Sub Project Id
  • Project Start Date
    7/1/2010 - 15 years ago
  • Project End Date
    12/31/2011 - 13 years ago
  • Program Officer Name
    FEINGOLD, ELISE A
  • Budget Start Date
    7/1/2010 - 15 years ago
  • Budget End Date
    12/31/2011 - 13 years ago
  • Fiscal Year
    2010
  • Support Year
    1
  • Suffix
  • Award Notice Date
    6/30/2010 - 15 years ago
Organizations

Development of a method to multiplex ChIP-SEQ and ChIP-chip experiments

DESCRIPTION (provided by applicant): The immediate objective of our research is to generate a method that will enable researchers to multiplex Chromatin ImmunoPreciptation-Sequencing (ChIP-Seq) analysis in a single Next generation DNA sequencing run. In the to-be-developed method: i) a set of antibodies directed against specific DNA-binding proteins are uniquely bar-coded with a DNA 'ZipCode;'ii) covalent cross-links between DNA-binding proteins and chromosomal DNA are formed by treating cells with formaldehyde;iii) the set of DNA-barcoded antibodies specific to the proteins of interest are used to selectively coimmunoprecipitate the protein-bound DNA fragments that were covalently cross-linked;iv) excess antibodies and chromosomal DNAs are removed by washing;v) the enriched protein-bound chromosomal DNA is ligated to the antibody-attached ZipCode DNA using T4 DNA ligase, and;vi) the immunoprecipitated protein-DNA links are reversed and the recovered DNA is assayed using Next-generation sequencers to determine both the chromosomal DNA sequence bound by the protein and the antibody-identifying DNA ZipCode. PUBLIC HEALTH RELEVANCE: Researchers will benefit from an increased understanding of the function of human proteins. Methods are needed that can facilitate this understanding. The immediate objective of our research is to generate a method that will enable researchers to multiplex the method known as Chromatin ImmunoPreciptation-Sequencing (ChIP-Seq) analysis, in a single DNA sequencing run. We anticipate using our high-throughput antibody-discovery pipeline for producing recombinant antibodies as a means to generate the reagents needed to make this multiplexed method possible.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R43
  • Administering IC
    HG
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    96738
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:96738\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    AFFOMIX, INC.
  • Organization Department
  • Organization DUNS
    623623803
  • Organization City
    Branford
  • Organization State
    CT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    064052971
  • Organization District
    UNITED STATES